GrowthOpportunity Target mid-sized biotechnology firms with revenue in the $1M–$10M range and 50–200 employees for collaboration on portable diagnostic solutions, leveraging Osmetech’s experience in point-of-care systems and recent micro-lysis tool launches.

NewProduct Capitalize on the MicroMesh Lysate Removal Transfer Pipettes launch to upsell complementary lab automation hardware, workflow optimization software, and consumables that reduce hands-on time and centrifugation steps.

FundingIndicator Leverage a history of grant-supported development to position for grant-aligned co-development deals or funded pilots with research institutions seeking portable and integrated diagnostic solutions.

CompetitivePosition Position Osmetech alongside peers in the mid-market life sciences segment by emphasizing efficiency gains, portability, and integrated assay capabilities to differentiate from larger incumbents.

StrategicPartnerships Explore partnerships with contract research organizations and academic labs that need scalable, low-complexity diagnostic workflows, offering bundled solutions that integrate existing cloud and analytics capabilities.